Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Messner

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Bone Marrow Transplantation|July 14, 2015
Patient age, remission status and HCT-CI in a combined score are prognostic for patients with AML undergoing allogeneic hematopoietic cell transplantation in CR1 and CR2F V Michelis, H A Messner, E G Atenafu, et al.
Leukemia Research|June 2, 2005
Treatment of elderly patients with acute lymphoblastic leukemia--evidence for a benefit of imatinib in BCR-ABL positive patientsJ M Brandwein, V Gupta, R A Wells, et al.
Bone Marrow Transplantation|March 31, 2015
Comparable outcomes post allogeneic hematopoietic cell transplant for patients with de novo or secondary acute myeloid leukemia in first remissionF V Michelis, E G Atenafu, V Gupta, et al.
Bone Marrow Transplantation|December 23, 2003
The role of allogeneic bone marrow transplantation in adult patients below the age of 55 years with acute lymphoblastic leukemia in first complete remission: a donor vs no donor comparisonV Gupta, Q-L Yi, J Brandwein, et al.
Current Oncology (Toronto, Ont.)|December 3, 2015
Human albumin eye drops as a therapeutic option for the management of keratoconjunctivitis sicca secondary to chronic graft-versus-host disease after stem-cell allograftingJ T Seki, N Sakurai, S Moldenhauer, et al.
Bone Marrow Transplantation|March 2, 2016
Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantationS Mayo, H A Messner, S B Rourke, et al.
Bone Marrow Transplantation|September 10, 2005
Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host diseaseC L Toze, A Galal, M J Barnett, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Bone Marrow Transplantation|July 14, 2015
Patient age, remission status and HCT-CI in a combined score are prognostic for patients with AML undergoing allogeneic hematopoietic cell transplantation in CR1 and CR2F V Michelis, H A Messner, E G Atenafu, et al.
Leukemia Research|June 2, 2005
Treatment of elderly patients with acute lymphoblastic leukemia--evidence for a benefit of imatinib in BCR-ABL positive patientsJ M Brandwein, V Gupta, R A Wells, et al.
Bone Marrow Transplantation|March 31, 2015
Comparable outcomes post allogeneic hematopoietic cell transplant for patients with de novo or secondary acute myeloid leukemia in first remissionF V Michelis, E G Atenafu, V Gupta, et al.
Bone Marrow Transplantation|December 23, 2003
The role of allogeneic bone marrow transplantation in adult patients below the age of 55 years with acute lymphoblastic leukemia in first complete remission: a donor vs no donor comparisonV Gupta, Q-L Yi, J Brandwein, et al.
Current Oncology (Toronto, Ont.)|December 3, 2015
Human albumin eye drops as a therapeutic option for the management of keratoconjunctivitis sicca secondary to chronic graft-versus-host disease after stem-cell allograftingJ T Seki, N Sakurai, S Moldenhauer, et al.
Bone Marrow Transplantation|March 2, 2016
Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantationS Mayo, H A Messner, S B Rourke, et al.
Bone Marrow Transplantation|September 10, 2005
Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host diseaseC L Toze, A Galal, M J Barnett, et al.
Pageof 13